Anti-tumor Necrosis Factor Drugs and Risk of Lymphoma in Patients with Inflammatory Bowel Disease

被引：0
|
作者：
Blandizzi, C. [1 ]
Tuccori, M. [1 ]
Ferraro, S. [1 ]
Leonardi, L. [1 ]
Convertino, I. [1 ]
机构：
[1] Univ Pisa, Unit Pharmacol & Pharmacovigilance, Dept Clin & Expt Med, Pisa, Italy
来源：
DRUG SAFETY | 2019年 / 42卷 / 10期
关键词：
THERAPY;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
77
引用
收藏
页码：1245 / 1245
页数：1
相关论文
共 50 条
  • [1] Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies
    Ferraro, Sara
    Leonardi, Luca
    Convertino, Irma
    Blandizzi, Corrado
    Tuccori, Marco
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [2] LOW RISK OF LYMPHOMA IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED USING ANTI-TUMOR NECROSIS FACTOR AGENTS
    Egberg, Matthew D.
    Smitherman, Andrew
    Zhang, Xian
    Kappelman, Michael
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S968 - S969
  • [3] LOW RISK OF LYMPHOMA IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED USING ANTI-TUMOR NECROSIS FACTOR AGENTS
    Egberg, Matthew
    Smitherman, Andrew
    Zhang, Xian
    Kappelman, Michael
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 : S2 - S3
  • [4] Risk factors for tuberculosis in inflammatory bowel disease: anti-tumor necrosis factor and hospitalization
    Riestra, Sabin
    de Francisco, Ruth
    Arias-Guillen, Miguel
    Saro, Cristina
    Garcia-Alvarado, Maria
    Duque, Jose M.
    Jose Palacios, Juan
    Munoz, Fernando
    Blanco, Lorena
    Castano, Olegario
    Perez-Martinez, Isabel
    Martinez-Camblor, Pablo
    Perez-Hernandez, Dolores
    Suarez, Adolfo
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2016, 108 (09) : 541 - 549
  • [5] Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease
    Cohen, Benjamin L.
    Sachar, David B.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
  • [6] Anti-Tumor Necrosis Factor Treatment of Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Jegadeesan, Ramprasad
    Kochhar, Gursimran
    Hayat, Umar
    Kim, Ahyoung J.
    Lan, Nan
    Sanaka, Madhusudhan R.
    Shen, Bo
    Romero-Marrero, Carlos
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S396 - S397
  • [7] Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease
    William J. Sandborn
    [J]. Current Gastroenterology Reports, 2003, 5 (6) : 501 - 505
  • [8] Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
    Yunho, Jung
    [J]. KOREAN JOURNAL OF GASTROENTEROLOGY, 2020, 75 (01): : 1 - 3
  • [9] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Frank Hoentjen
    Ad A van Bodegraven
    [J]. World Journal of Gastroenterology, 2009, 15 (17) : 2067 - 2073
  • [10] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Hoentjen, Frank
    Van Bodegraven, Ad A.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (17) : 2067 - 2073
12345